Cepheid

📍 Sunnyvale, United States🗓 Founded 1996👥 4,879 employees💰 Last funded Jan 2006
Biotechnology Research🌐 cepheid.com
Website LinkedIn
Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. The companys GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform world-class PCR testing. Cepheid’s broad test portfolio spans respiratory infections, blood virology, women’s and sexual health, TB and emerging infectious diseases, healthcare-associated infectious diseases, oncology and human genetics. The company’s solutions deliver actionable results where they are needed most – from central laboratories and hospitals to near-patient settings. For more information, visit http://www.cepheid.com. Cepheid is proud to be a part of Danaher. Danaher’s science and technology leadership puts Cepheid’s solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers. Together with Danaher’s other businesses across Biotechnology, Diagnostics, and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
1996
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Cepheid?
Cepheid has 1 investors on record on gritt.io.
When did Cepheid last raise funding?
The most recent investment in Cepheid recorded on gritt.io was in January 2006.
When was Cepheid founded?
Cepheid was founded in 1996.
What industry is Cepheid in?
Cepheid operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Cepheid based?
Cepheid is headquartered in Sunnyvale, United States.